Ovary
| Primary Site | Histology |
|---|---|
| C569 | 8000-8700, 8720-8790, 8806, 8810, 8815, 8822, 8825, 8890, 8930-8931, 8933, 8935-8936, 8950, 8960, 8980, 9000, 9050, 9052, 9060, 9070-9071, 9073, 9080, 9085, 9090-9091, 9100, 9110-9111 |
Notes
8000-8700, 8720-8790, 8806, 8810, 8815, 8822, 8825, 8890, 8930-8931, 8933, 8935-8936, 8950, 8960, 8980, 9000, 9050, 9052, 9060, 9070-9071, 9073, 9080, 9085, 9090-9091, 9100, 9110-9111 C569 Ovary **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 55 *Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * 8710-8714, 8800-8803, 8811-8814, 8816-8818, 8820-8821, 8823-8824, 8826-8858, 8860-8881, 8891-8900, 8902-8905, 8921, 8932, 8934, 8940-8941, 8951-8959, 8963-8976, 8981-8990, 8992, 9010-9016, 9030-9043, 9045, 9051, 9053-9055, 9061-9065, 9072, 9081-9084, 9086, 9101-9105, 9121-9132, 9135-9138, 9141-9175, 9181-9221, 9230, 9240-9365, 9370-9580, 9582: *Soft Tissue Other* * 8804-8805, 8859, 8901, 8910-8920, 8991, 9020, 9044, 9120, 9133, 9180, 9222, 9231, 9366-9368, 9581: *Soft Tissue Rare* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides*Data Items
| Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
| Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
| Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
| Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
| Tumor Size Clinical | <BLANK> | No |
NAACCR #752
tumorSizeClinical |
None | |
| Tumor Size Pathological | <BLANK> | No |
NAACCR #754
tumorSizePathologic |
None | |
| Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| RX Summ Surgery/Radiation Sequence | <BLANK> | No |
NAACCR #1380
rxSummSurgRadSeq |
None | |
| RX Summ Systemic/Surgery Sequence | <BLANK> | No |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
| Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
| Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
| Grade Post Therapy Clin (yc) | <BLANK> | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI |
| Grade Post Therapy Path (yp) | <BLANK> | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI |
| FIGO Stage | 98 | No |
NAACCR #3836
figoStage |
COC SEER |
SSDI |
| CA-125 PreTx Interpretation | 8 | No |
NAACCR #3818
ca125PretreatmentInterpretation |
CCCR/Canada COC SEER |
SSDI |
| Residual Tumor Volume Post Cytoreduction | 98 | No |
NAACCR #3921
residualTumVolPostCytoreduction |
COC SEER |
SSDI |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Schema ID | 00551 |
NAACCR #3800
schemaId |
None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
| Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |